Regenerative Medicine

Regenerative medicine is an emerging, multidisciplinary sector to develop innovative therapies to repair or replace organs and tissues impaired by disease or injury.

The focus of regeNer8 (the N8 Centre for Translational Regenerative Medicine) is on safer translation in regenerative medicine - an area identified by industrial and clinical stakeholders as the major barrier to commercialisation of regenerative therapies - which will accelerate the development of these regenerative therapies and bring them through to clinic and market.

"The regeNer8 project has been important in identifying key translational elements associated with development of the porcine heart valve and will have played a role in risk management of this key project. The grant has enabled us to focus on the primary obstacles to success in this area which should and could reduce its time to market."
Antony Odell, CEO of Tissue Regenix Ltd

Contacts

Research Director: Professor John Fisher
(Professor of Mechanical Engineering and Director of the Institute for Medical and Biological Engineering, University of Leeds)

Business Development Manager: Dr Bridget Matthews
Tel: 0113 397 0326
Email: bridget.matthews@bitecic.com
Website: www.regener8.ac.uk